617 POSTER Initial safety findings from XELOXA: a randomised phase III trial of capecitabine plus oxaliplatin vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with stage III colon cancer

• Book ID: 118623194
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 122 KB
• Volume: 3
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(05)80913-9